Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot–Marie–Tooth disease

Overview of attention for article published in Brain, July 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 72,802 followers.

Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot-Marie-Tooth disease https://t.co/u0A3OMcO89 https://t.co/2Fn5LWPnoO

RT @NatRevNeurol: Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot-Marie-Tooth disease https://t.co/…

Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot-Marie-Tooth disease https://t.co/EOJOtQoW6q

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.